Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

PharmAthene, Inc. (PIP)

-NYSE MKT
1.42 Down 0.02(1.39%) Apr 17, 4:03PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 3,654   3,488   4,295   6,475  
Cost of Revenue -   -   -   -  
Gross Profit 3,654   3,488   4,295   6,475  
Operating Expenses
Research Development4,098  2,556  3,403  5,233  
Selling General and Administrative4,580  4,086  2,333  2,280  
Non Recurring -   -   -   -  
Others43  45  42  53  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (5,068) (3,199) (1,482) (1,091)
Income from Continuing Operations
Total Other Income/Expenses Net734  (628)357  (911)
Earnings Before Interest And Taxes(4,333)(3,827)(1,125)(2,002)
Interest Expense80  90  100  100  
Income Before Tax(4,413)(3,917)(1,225)(2,102)
Income Tax Expense12  29  11  10  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(4,425)(3,946)(1,236)(2,111)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (4,425) (3,946) (1,236) (2,111)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (4,425) (3,946) (1,236) (2,111)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.